Detalhe da pesquisa
1.
Continuous versus intermittent oral administration of levodopa in Parkinson's disease patients with motor fluctuations: A pharmacokinetics, safety, and efficacy study.
Mov Disord
; 34(3): 425-429, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30653246
2.
Gene delivery of neurturin to putamen and substantia nigra in Parkinson disease: A double-blind, randomized, controlled trial.
Ann Neurol
; 78(2): 248-57, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26061140
3.
Factors predictive of the development of Levodopa-induced dyskinesia and wearing-off in Parkinson's disease.
Mov Disord
; 28(8): 1064-71, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23630119
4.
Milestones in magnetic resonance imaging and transcranial sonography of movement disorders.
Mov Disord
; 26(6): 979-92, 2011 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-21626543
5.
Placebo influences on dyskinesia in Parkinson's disease.
Mov Disord
; 23(5): 700-7, 2008 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18175337
6.
Distribution and immunohistochemical characterization of torsinA immunoreactivity in rat brain.
Brain Res
; 900(2): 348-54, 2001 May 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-11334819